🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a phase I trial to determine the maximum tolerated dose and recomme...
Status
Completed
Location
Asan Medical Center
Start Date
2010-04
Trial ID
NCT01103791
Treatments Being Tested
The epidermal growth factor receptor (EGFR) is both oncogene and prognostic...
Status
Completed
Location
UPMC Presbyterian
Start Date
2015-08
Trial ID
NCT02277197
Treatments Being Tested
This is a single arm phase II trial of Gemcitabine and Oxaliplatin (Gem-Ox)...
Status
Terminated
Location
California Pacific Medical Center
Start Date
2007-08
Trial ID
NCT00832637
Treatments Being Tested
This is a Phase I multicenter, open-label, dose-ranging, three-dose PK and ...
Status
Active Not Recruiting
Location
University of California, Davis
Start Date
2020-03-03
Trial ID
NCT04143659
Treatments Being Tested
This is an open-label, Phase I/Ib, dose escalation study of intravenous RXD...
Status
Terminated
Location
Florida Cancer Specialists
Start Date
2015-09
Trial ID
NCT02548390
Treatments Being Tested
The maximum tolerated dose (MTD) of E7389 liposomal formulation (E7389-LF) ...
Status
Active Not Recruiting
Location
Eisai Trial Site 3
Start Date
2017-08-18
Trial ID
NCT03207672
Treatments Being Tested
The purpose of this study is to evaluate the efficacy and safety of 177Lu-T...
Status
Recruiting
Location
Chao Family Comprehensive Cancer Centre
Start Date
2024-07-26
Trial ID
NCT06520345
Treatments Being Tested
The proposed study is of a Liposomal formulation of cytarabine and daunorub...
Status
Withdrawn
Location
Yale University; Smilow Cancer Center
Start Date
2019-12-30
Trial ID
NCT04109690
Treatments Being Tested
The investigators have formulated an oral preparation of arsenic trioxide (...
Status
Recruiting
Location
The University of Hong Kong
Start Date
2021-01-01
Trial ID
NCT04687176
Treatments Being Tested
A first-in-human open-label, Phase I/II study to evaluate the safety, toler...
Status
Terminated
Location
Scripps Clinic Torrey Pines
Start Date
2018-07-02
Trial ID
NCT03592264
Treatments Being Tested